European Journal of Pharmaceutical Sciences

Papers
(The H4-Index of European Journal of Pharmaceutical Sciences is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board377
Aerosol delivery of inhalation devices with different add-on connections to invasively ventilated COPD subjects: An in-vivo study147
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification112
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia110
Development of cationic Isometamidium chloride loaded long-acting lipid nanoformulation: optimization, cellular uptake, pharmacokinetics, biodistribution, and immunohistochemical evaluation104
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue86
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer79
Molecular characteristics of several drugs evaluated from solvent/water partition measurements: Solvation parameters and intramolecular hydrogen bond indicator77
Pre-miRNA-149 G-quadruplex as a molecular agent to capture nucleolin71
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin70
Opportunities of topical drug products in a changing dermatological landscape69
Impact of protein adsorption during biopharmaceutical manufacture & storage67
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases57
In vitro identification of decreased function genetic variants of ABCB157
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets56
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy55
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways55
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material52
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma52
Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation50
3D printed extended-release hydrochlorothiazide tablets48
Evaluation of Transmission Raman spectroscopy and NIR Hyperspectral Imaging for the assessment of content uniformity in solid oral dosage forms✰47
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study45
Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model45
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo43
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system43
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos41
Microparticles and multi-unit systems for advanced drug delivery41
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis40
Dissolving microneedles with antibacterial functionalities: A systematic review of laboratory studies39
Towards optimization of dexamethasone therapy in the maintenance phase of pediatric acute lymphoblastic leukemia: A population pharmacokinetic and pharmacodynamic study of dexamethasone and metabolite37
In Vitro and In Vivo Evaluation of Dark Chocolate as Age-appropriate Oral Matrix37
Low-dose apatinib in subjects with renal impairment: A pharmacokinetics study37
Role of exosomes in bone and joint disease metabolism, diagnosis, and therapy37
Preclinical characterization of a novel potent core protein assembly modulator for the treatment of chronic hepatitis B viral infection37
Virtual special issue of Nordic POP: Patient-oriented products37
Exploring Kp,uu,BBB values smaller than unity in remoxipride: A physiologically-based CNS model approach highlighting brain metabolism in drugs with passive blood-brain barrier transport36
Stability evaluation from hydrogen peroxide spiking studies36
0.20912194252014